'Wake up and smell the roses'--a drug reaction to etidronate
Burnet, S.P.; Petrie, J.P.
Australian and New Zealand Journal of Medicine 29(1): 93
1999
ISSN/ISBN: 0004-8291 PMID: 10200824 Document Number: 505557
Document emailed within 1 workday
Related Documents
Bogart, D.B. 2016: Life After Medicine: a time to Smell the Roses Missouri Medicine 113(3): 176-177Ashton, T. 2013: The New Zealand health system after 75 years: let's stop and smell the roses New Zealand Medical Journal 126(1380): 6-8
Kaolawanich, A.; Assanasen, P.; Tunsuriyawong, P.; Bunnag, C.; Tantilipikorn, P. 2009: Smell disorders: a study of 132 patients from the first Smell and Taste Clinic of Thailand Journal of the Medical Association of Thailand 92(8): 1057-1062
Miller, P.D. 1996: Critical drug appraisal: etidronate intermittent cyclic therapy for postmenopausal osteoporosis British Journal of Clinical Practice 50(1): 23-31
Gastpar, H. 1986: Drug side effects on the nasal mucosa and sense of smell Laryngologie Rhinologie Otologie 65(8): 415-419
Edgar, D.M. 2002: Signature profiles in sleep-wake drug discovery Methods and Findings in Experimental and Clinical Pharmacology 24 Suppl D: 71-72
Patel, M.J.; Shahid, M.; Riaz, M.; Kashif, W.; Ayaz, S.I.; Khan, M.S.; Samdani, A.J.; Sorathia, A.L.; Furqan, M. 2008: Drug overdose: a wake up call! Experience at a tertiary care centre in Karachi, Pakistan JPMA. Journal of the Pakistan Medical Association 58(6): 298-301
Wang, D.; Du, X-Xi. 2012: Interpretation of adverse drug reaction reporting and monitoring and significance of traditional Chinese medicine adverse drug reaction monitoring Zhongguo Zhong Yao Za Zhi 37(18): 2686-2688
Lagier, G.; Vincens, M.; Castot, A. 1983: Imputability in drug monitoring. Principles of the balanced drug reaction assessment method and principal errors to avoid Therapie 38(3): 303-318
Nowak, R. 2006: Determination of ellagic acid in pseudofruits of some species of roses Acta Poloniae Pharmaceutica 63(4): 289-292
Marshall, E.; Roses, A. 1998: Allen Roses: from 'street fighter' to corporate insider Science 280(5366): 1001-1004
Inui, K.; Takaoka, K. 2003: Etidronate Nihon Rinsho. Japanese Journal of Clinical Medicine 61(2): 226-230
Yang, Y-Yin.; Dong, Z.; Xia, Y-Peng. 2012: Discussion on adverse reactions monitoring modes of drug manufacturers under new measures for administration of adverse drug reaction report and monitoring Zhongguo Zhong Yao Za Zhi 37(21): 3329-3333
Horowitz, E.; Miller, J.L.; Rose, L.I. 1991: Etidronate for hypercalcemia of malignancy and osteoporosis American Family Physician 43(6): 2155-2159
Terranova, R.; Luca, S. 1999: Treatment of postmenopausal osteoporosis with etidronate Minerva Medica 90(3): 85-90
Shield, C.F. 1987: Unusual drug reaction Veterinary Record 121(21): 504
Muir, H.G.; Schabort, I.; Hough, F.S. 1987: Influence of disodium etidronate on Paget's disease of bone South African Medical Journal 72(7): 470-472
Porter, C.B.; Goldberg, A.T.; Fritts, K.W. 1981: Adverse reaction to a nonepinephrine hemostatic drug General Dentistry 29(2): 134-135
Deshpande, N.S. 1993: Adverse drug reaction monitoring of ciprofloxacin Indian Pediatrics 30(7): 942-943
Makdisi, J.; Amin, B.; Friedman, A. 2013: Pityriasis rosea-like drug reaction to asenapine Journal of Drugs in Dermatology: Jdd 12(9): 1050-1051